RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.04+0.09 (+8.91%)
Close on Nov 17, 2026Market cap $46.93MP/E –Yield –
RenovoRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
RenovoRx's revenue for the twelve months ending Jun 30, 2026 was $1.98M. For fiscal 2025 it was $1.12M, up 2511.6% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12M | +2511.6% |
| FY2024 | Dec 31, 2024 | $43.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $909.00K | +115.4% |
| Q1 FY2026 | Mar 31, 2026 | $563.00K | +185.8% |
| Q4 FY2025 | Dec 31, 2025 | $238.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $266.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $422.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $197.00K | – |
See a number that looks wrong?